A new open-source software package provides fast, modular tools for extracting interpretable cis-regulatory patterns from deep learning models of the genome.

Languages that got robbed by the hype cycle!

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

MIT’s Alex Zhang reveals why OpenAI and Anthropic coding agents are basically the same, sparking debate in AI development ...

Recursion Pharmaceuticals recorded 5 insider transactions totaling $514,889.42 across 2 transaction types. Tax payments accounted for 4 of 5 transactions and $436,067.04 of total value; the lone sale ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.